EAM Investors’s Dermira, Inc. DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-126,446
Closed -$1.92M 324
2019
Q4
$1.92M Buy
+126,446
New +$1.09M 0.42% 87
2019
Q2
Sell
-181,513
Closed -$2.46M 337
2019
Q1
$2.46M Buy
+181,513
New +$1.51M 0.6% 44
2017
Q2
Sell
-78,098
Closed -$2.66M 398
2017
Q1
$2.66M Buy
78,098
+59,874
+329% +$1.93M 0.42% 127
2016
Q4
$553K Sell
18,224
-115,408
-86% -$3.72M 0.07% 298
2016
Q3
$4.52M Buy
133,632
+22,273
+20% +$717K 0.61% 16
2016
Q2
$3.26M Buy
+111,359
New +$3.07M 0.49% 41
2016
Q1
Sell
-33,378
Closed -$1.16M 375
2015
Q4
$1.16M Sell
33,378
-11,794
-26% -$339K 0.15% 248
2015
Q3
$1.05M Buy
+45,172
New +$1.1M 0.17% 253

EAM Investors's DERM Position: Q1 2020 in Review

EAM Investors sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 126,446 shares — an estimated $1.92M sold.

EAM Investors first reported a position in DERM in Q3 2015 and held it in 8 quarters. The position peaked at $4.52M in Q3 2016. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

  • EAM Investors reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
  • EAM Investors sold 126,446 Dermira, Inc. shares in Q1 2020, an estimated $1.92M.
  • EAM Investors first reported a position in Dermira, Inc. in Q3 2015 and held it in 8 quarters.
  • EAM Investors's Dermira, Inc. position peaked at $4.52M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on EAM Investors's 13F filing for Q1 2020, filed 13 May 2020.